LOGO
LOGO

Edwards Lifesciences Corp. Is Pulling Back After Q4 Report

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Edwards Lifesciences Corp. (EW) reported fourth quarter EPS of $0.84 after the bell Thursday, which fell short of the consensus estimate of $0.85. The company expects to report first quarter EPS of $0.77 to $0.81 and full year 2010 EPS of $3.50 to $3.60. The consensus estimates are for EPS of $0.82 and $3.56. The stock is now down 2.36 on 29K shares.

Edwards Lifesciences fell in the first hour of trade Thursday and declined for the majority of the afternoon. Shares finished down by 2.78 at $89.66 on above average volume.

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.